Practical Considerations on the FDA CFL Guidance
Thursday, June 25, 2020 | Noon CST
This webinar will include a 45 minute presentation and 10 to 15 minutes of Q&A.
- Internal Collaborations and Concept Review
- Practical considerations for implementing the CFL Guidance
- Best practices in applying the three CFL factors
This webinar is available to single attendees for $249.
For teams, three logins are available for $395.
Regulatory Affairs, Advertising & Promotion
Promotional Regulatory Affairs
Advertising & Promotional Review
Regulatory Affairs Advertising, Promotion & Labeling
Regulatory Affairs – Commercialization
Arnold & Porter
Abraham Gitterman is a Life Sciences/Healthcare Associate at Arnold & Porter Kaye Scholer LLP in Washington, DC, where he focuses on FDA and healthcare regulatory, compliance, and fraud and abuse matters involving pharmaceutical and medical device manufacturers. He regularly counsels clients on FDA-regulated advertising and promotion, including use of digital and social media; compliant medical affairs activities, including continuing medical education (CME); appropriate interactions with healthcare professionals; and mobile health applications. Mr. Gitterman currently and regularly serves on Promotional Review Committees (PRCs) across various therapeutic areas and throughout product life cycles.
For More Information, Contact:
Division Director, Life Science Programs
+1 (312) 224-1693